Mixed Institutional Activity Amid Stock Lows
Key Questions
What recent institutional activity has occurred in Lululemon Athletica ($LULU) stock during Q4?
Institutional activity in $LULU has been mixed, with notable buying amid stock lows. Buyers include Azzad (+66% to 19k shares/$4.1M), Assenagon (+255% to 438k shares/$91M), Invesco Nasdaq100 (+37k to 418k shares/$77M), WealthNavi (+36k shares), and new position by Robinhood (24k shares/$5M). Sellers include IMC-Chicago (-70%) and Caldwell (-97%, tiny position).
Which institutions significantly increased their $LULU holdings?
Assenagon increased by 255% to 438k shares worth $91M, Invesco Nasdaq100 added 37k shares to reach 418k shares/$77M, and Azzad grew 66% to 19k shares/$4.1M. WealthNavi added 36k shares, while Robinhood initiated a new position of 24,719 shares worth $5M. This dip buying occurred at $152-156 lows despite perceived weakness and undervaluation.
Did Robinhood Asset Management recently buy $LULU shares?
Yes, Robinhood Asset Management LLC bought 24,719 shares of Lululemon Athletica ($LULU), establishing a new position valued at approximately $5M. This move aligns with broader dip buying by institutions at stock lows around $152-156.
Which institutions reduced their $LULU positions recently?
IMC-Chicago reduced its holdings by 70%, and Caldwell Trust Co sold 3,413 shares, cutting its position by 97% to a tiny remaining stake. Comerica Bank also sold 617 shares. These sales contrast with significant buying from other institutions amid stock undervaluation concerns.
What is the context of dip buying in $LULU stock?
Institutions engaged in dip buying at $152-156 lows, viewing the stock as undervalued despite recent weakness. Major buyers like Assenagon and Invesco added substantial positions in Q4, signaling confidence. This mixed activity highlights divergent views on $LULU's prospects.
Q4 Azzad +66% 19k/$4.1M/Assenagon +255% 438k/$91M/Invesco Nasdaq100 +37k 418k/$77M/Wealth +36k/Robinhood new 24k/$5M; IMC-Chicago -70%/Caldwell -97% tiny; dip buying at $152-156 lows vs weakness/undervaluation.